Where it is registered
Each register with its number of medicines and a few of them.
All medicines with Conjugated
Every register, a page at a time. Strengths and packs are on each medicine’s page.
85 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Conjugated EstrogensCombination | United States | 0.3MG, 0.45MG, 0.625MG … | tablet | Marketed | Novast Labs |
| PremarinCombination | United States | 0.3MG, 0.45MG, 0.625MG … | tablet | Marketed | Wyeth Pharms |
| Premphase 14/14Combination | United States | 0.625MG,0.625MG; 5MG | tablet | Marketed | Wyeth Pharms |
| PremproCombination | United States | 0.3MG; 1.5MG, 0.45MG; 1.5MG, 0.625MG; 2.5MG … | tablet | Marketed | Wyeth Pharms |
| PremarinCombination | United States | 25MG/VIAL | injectable | Marketed | Wyeth Pharms |
| PremarinCombination | United States | 0.625MG/GM | cream | Marketed | Wyeth Pharms |
| Prempro (Premarin;Cycrin)Combination | United States | 0.625MG,0.625MG; 2.5MG,2.5MG | tablet | Not marketed | Wyeth Pharms INC |
| Premphase (Premarin;Cycrin 14/14)Combination | United States | 0.625MG,0.625MG; 5MG | tablet | Not marketed | Wyeth Pharms INC |
| Milprem-200Combination | United States | 0.45MG; 200MG | tablet | Not marketed | Medpointe Pharm HLC |
| Milprem-400Combination | United States | 0.45MG; 400MG | tablet | Not marketed | Medpointe Pharm HLC |
| PMB 200Combination | United States | 0.45MG; 200MG | tablet | Not marketed | Wyeth Ayerst |
| PMB 400Combination | United States | 0.45MG; 400MG | tablet | Not marketed | Wyeth Ayerst |
| DuaveeCombination | United States | 20MG BASE; 0.45MG | tablet | Marketed | Wyeth Pharms |
| Synthetic Conjugated Estrogens ACombination | United States | 0.625MG/GM | cream | Not marketed | Teva Womens |
| Prempro/Premphase | United States | 0.45MG/1.5MG & 0.3MG/1.5MG | Tablet | Marketed | Wyeth Ayerst |
| EnjuviaCombination | United States | 0.3MG, 0.45MG, 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet | Not marketed | Aspen |
| CenestinCombination | United States | 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.45MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** … | tablet | Not marketed | Aspen |
| PMS-Conjugated Estrogens C.S.D. | Canada | 0.3 MG | Tablet | Cancelled | Pharmascience INC |
| PMS-Conjugated Estrogens C.S.D. | Canada | 0.9 MG | Tablet | Cancelled | Pharmascience INC |
| PMS-Conjugated Estrogens C.S.D. | Canada | 1.25 MG | Tablet | Cancelled | Pharmascience INC |
| PMS-Conjugated Estrogens C.S.D. | Canada | 0.625 MG | Tablet | Cancelled | Pharmascience INC |
| DuaviveCombination | European Union | Authorised | Pfizer Europe MA EEIG | ||
| Congest | Canada | 0.9 MG | Tablet | Not marketed | Laboratoire Riva INC. |
| Congest | Canada | 2.5 MG | Tablet | Not marketed | Laboratoire Riva INC. |
| Congest | Canada | 0.625 MG | Tablet | Not marketed | Laboratoire Riva INC. |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Often combined with
Substances it shares a medicine with.
Sources
Compiled by Prognia from the public medicine registers of FDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 1
- Medicines
- 13
- Companies
- 4